Genitourinary Syndrome of Menopause is a constellation of symptons arising from a reduced level of estrogen either from progression through natural menopause or in situations where estrogen deficiency is induced by cancer treatment. If left untreated these symptoms can contribute to dimished quality of life and impaired sexual function.
A specialized new CO2 fractional laser (MonoLisa Touch® ) is now available specifically for vaginal restoration and vulval symptoms resulting from low estrogen states in women with intolerance to estrogen replacement such as:
Following breast cancer treatment
A history of thrombophlebitis
Peri and post menopause with an inadequate response to estrogen replacement
Following childbirth while nursing
Previously called atrophic vaginitis and now referred to as Genitourinary Syndrome of Menopause (GMS) is a condition presenting as
- dryness and painful intercourse (dyspareunia)
- recurrent urinary tract infections and
- urinary stress incontinence
Up to now estrogen creams have mostly been the main mode of treatment, but for breast cancer survivors and others these may be contraindicated.
An alternative treatment is fractional CO2 laser.
MonaLisa Touch Laser delivers gentle laser energy, to the vaginal wall tissue, that stimulates a healing response by generating new collagen, elastin and vascularization. A typical course of treatment is three procedures 6 weeks apart and involves:
- In-office procedure by a gynecologist
- Requiring no anesthesia
- No downtime
- Minimal side effects
- Each treatment is <5 minutes
- 8 Published Studies
- 6 Ongoing Studies
- Thousands of women have been treated worldwide since 2012
In both European and US clinical trials, women reported symptom relief after the very first treatment and even greater improvement after treatments 2 and 3.
Contact ..hide 604 558 4886 Dr Anthony Cheung -Grace Fertility Centre